StageZero Life Sciences, Ltd. Announces Temporary Repricing of Warrants Expiring in 2023 and 2024

Stock Information for StageZero Life Sciences Ltd.

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About StageZero Life Sciences Ltd.

StageZero Life Sciences Provides an Update on Application for Management Cease Trade Order
StageZero Life Sciences Announces Delay to Fourth Quarter and Year End 2023 Financial Results
StageZero Life Sciences, Ltd Announces Q3 2023 Financial Results and Operational Update
StageZero Life Sciences Partners with My One Medical Source and 1,000+ Medical Access Points in the USA
StageZero Life Sciences' Clinical Business Introduces Fourth Pillar to Cancer Offerings
StageZero Life Sciences' Clinical Business Introduces Third Pillar to Cancer Offerings
StageZero Life Sciences, Ltd Announces Results of Resolutions at Annual and Special Meeting
StageZero Life Sciences, Ltd. Special and Annual General Meeting Conference Call

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.